Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer

Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer
ShareXFacebook

(MedPage Today) -- SAN JUAN, Puerto Rico -- Almost 100% of patients with recurrent/metastatic endometrial cancer benefited from an investigational bispecific antibody plus standard chemotherapy, according to a small preliminary study from China...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

America's Forgotten War on Drugs
MedPage Today

America's Forgotten War on Drugs

(MedPage Today) -- Platzspitz is a small park located behind the Hauptbahnhof, Zurich's buzzing central train station, and the imposing Swiss National Museum. Today, it's quiet and secluded, a small green where families picnic and tour groups reconvene...

Read more →
Advertisement